Concepedia

Ana Bercovici

AB

Statistics

Publications

12

Citations

279

H-Index

11

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

AGCO (United Kingdom)

Albany Molecular Research (United States)

Ana Bercovici is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and neuropharmacology.

Publications per year

1997–2014

12

Publications

12

Potent Tetracyclic Guanine Inhibitors of PDE1 and PDE5 Cyclic Guanosine Monophosphate Phosphodiesterases with Oral Antihypertensive Activity

Ho-Sam Ahn, Ana Bercovici, George Boykow et al. · Journal of Medicinal Chemistry · 1997 · 80 citations · Full text

, , +16

The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia

Ginny D. Ho, Shu‐Wei Yang, Jennifer Smotryski et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 33 citations · Full text

, , +6

The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia

Ginny D. Ho, W. Michael Seganish, Ana Bercovici et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 26 citations · Full text

, , +10

The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxiety

Ginny D. Ho, John C. Anthes, Ana Bercovici et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 25 citations · Full text

, , +14

The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): Comparison of efficacy and side effects across rodent species

Sherry Lu, Guy A. Higgins, Robert A. Hodgson et al. · European Journal of Pharmacology · 2011 · 23 citations

, , +11

1–5 of 12